Has Henry Chu, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,623 in general payments to Henry Chu, MD across 26 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Henry Chu, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Henry Chu, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Henry Chu, MD

Interventional Cardiology · Vancouver, WANPI 1023389061

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,447 of the $1,623 with a category attached, or 89.2%. 6 manufacturers reported payments, led by Abbott at 49.2% of the total. Reporting peaked in 2021 at $580 and has fallen 95.7% since, to $25 in 2025. That places this record below the midpoint for interventional cardiology clinicians in WA, where the typical reported total is $3,955.

$1,623in general payments, 2019–2025

Across 26 payments — averaging $62.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$798
Boston Scientific$598
Abiomed$93
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$80
Shockwave Medical, Inc$35
Edwards Lifesciences$19

What the payments were for

Grants$1006%
Food & beverage$1,44789%
Education$765%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	8	$798
Boston Scientific	12	$598
Abiomed	1	$93
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$80
Shockwave Medical, Inc	2	$35
Edwards Lifesciences	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,623 in reported general payments places this provider in the 30th percentile of 125 interventional cardiology providers in Washington.

See all interventional cardiology providers in Washington →

Medicare billing

Part B allowed, 2024

$105,204

Medicare patients

261

Services billed

1,037

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	240	$326,386
EntrestoSacubitril/Valsartan	41	$63,070
Repatha SureclickEvolocumab	42	$38,805
Repatha PushtronexEvolocumab	33	$23,856
XareltoRivaroxaban	12	$17,053
BrilintaTicagrelor	11	$12,814
Ethacrynic Acid	11	$11,340
VascepaIcosapent Ethyl	15	$8,595
Praluent PenAlirocumab	12	$6,247
Metoprolol Succinate	329	$4,143
Atorvastatin Calcium	341	$3,678
Ranolazine ErRanolazine	41	$3,552
ClopidogrelClopidogrel Bisulfate	180	$2,489
Rosuvastatin Calcium	122	$2,230
Isosorbide Mononitrate ErIsosorbide Mononitrate	105	$1,872

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Vancouver

Vishesh KumarVancouver$95K
Nathan BoyerVancouver$13K
Timothy SimpsonVancouver$13K
Shenjing LiVancouver$4K
William LombardiSeattle$902K
Kathleen KearneySeattle$448K
Robert RileyBellevue$431K
Danny DvirSeattle$374K
James McCabeSeattle$289K
Christopher BrownSeattle$266K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →